Edward Robert Smith, MD

Edward Robert Smith, MD

Director, Pediatric Cerebrovascular Neurosurgery; Co-Director, Cerebrovascular Surgery and Interventions Center; Co-Director, Head, Neck and Skull Base Surgery Program; Associate in Neurosurgery

Associate Professor, Harvard Medical School

"Together with my colleagues at Boston Children's Hospital, we have developed world-class programs to treat cerebrovascular disease and brain tumors through ongoing clinical innovation."

Medical Services


  • Aneurysms
  • Arteriovenous Malformation (AVM)
  • Brain Tumors
  • Cavernous Malformations
  • Chiari Malformations
  • Neurosurgery
  • Moyamoya
  • Neurotrauma
  • Stroke
  • Pituitary Tumors
  • Skull Base Lesions
  • Vascular Anomalies


  • Neurosurgery
  • Hematology / Oncology


  • English


  • Brain Tumor Center
  • Brain Injury Center
  • Cerebrovascular Surgery and Intervention Center
  • Stroke and Cerebrovascular Center
  • Moyamoya Disease Program
  • Neurosurgical Service
  • Vascular Anomalies Center
  • Vascular Biology Program
To schedule an appointment: Call 617-355-6008 or Request an Appointment
Edward Robert Smith, MD

I was drawn to neurosurgery—and to Boston Children's Hospital and training with Emeritus Neurosurgeon-in-Chief R. Michael Scott in particular—when my good friend in high school was treated here for a brain tumor. 

That experience started me on my path to becoming a pediatric neurosurgeon and after that, Dr. Scott's name echoed in the back of my head as I entered medical school to begin my studies.

I was reintroduced to Dr. Scott when I was a medical student at Columbia University. The neurosurgery department's chair there at the time, Ben Stein, was a former partner of Dr. Scott's and encouraged me to go and work with him. I completed a rotation here and then quickly followed that up with a fellowship under Dr. Scott's guidance. I have been at Boston Children's ever since, and am indebted to Dr. Scott for helping me to become a leader in the treatment of moyamoya syndrome, cerebrovascular disease and brain tumors.

I believe strongly in my role as a surgeon/scientist, and, in the laboratory, am lucky to have been mentored by Marsha A. Moses, a great scientist and the director of the Vascular Biology Program here at Boston Children's.

I'm a New Englander, having grown up in Dartmouth, MA, followed by my undergraduate years studying biology and rowing at Dartmouth College. My patients often give me joke books, which might be a reflection on my sense of (or lack of!) humor and desire to try to keep kids laughing if at all possible during difficult circumstances.

Experience and Education


Undergraduate Degree

Dartmouth College, 1992

Hanover, New Hampshire

Medical Degree

Columbia University, 1996

New York, New York


Massachusetts General Hospital, 1996-1997

Boston, Massachusetts


Neurosurgery - Massachusetts General Hospital, 1997-2003

Boston, Massachusetts


Boston Children's Hospital, 2003-2004

Boston, Massachusetts


  • ABNS - American Board of Neurological Surgery

  • ABPNS - American Board of Pediatric Neurological Surgery

  • Neurological Surgery, Pediatric Neurological Surgery

Professional History

I focus my practice on treating patients with cerebrovascular disease and brain tumors, with a particular focus on moyamoya syndrome, arteriovenous malformations and skull base tumors. Together with my colleagues at Boston Children's Hospital, we have developed world-class programs to treat these conditions through ongoing clinical innovation.

Under the tutelage of Dr. R. Michael Scott, we have continued to refine a novel, cutting-edge surgery for children with moyamoya based on the procedure of pial synangiosis, pioneered by Dr. Scott here at Boston Children's. Surgery has proven to be the only effective long-term treatment for this disease and we are a global leader in treating children with this disorder. Our department heads one of the world's largest pediatric moyamoya programs, with 40 to 50 operations annually and more than 1,000 revascularization procedures performed overall. This high-volume international practice is mirrored throughout our department, particularly in regard to cerebrovascular malformations and brain tumors. This has enabled me and my colleagues to develop a number of important innovations, including advances in minimally invasive skull base endoscopic techniques in young children and new perioperative and surgical approaches for moyamoya and arteriovenous malformation patients. 

This clinical expertise has led to authoring a number of important guidelines and articles about these conditions. I have tried to work on a national level to drive research on pediatric neurosurgical diseases, including in my roles as former president of the Young Neurosurgeons Committee of the American Association of Neurological Surgery, the current chair of the national research committee for the pediatric section of neurological surgery and the ethics committee of the American Society of Pediatric Neurosurgery, while also lecturing and teaching nationally and internationally.

This work is equally focused here at home. In 2014, together with my colleague and friend Darren Orbach, we founded the Cerebrovascular Surgery and Intervention Center—a first-of-its-kind program that integrates translational research into clinical efforts. This center includes a dedicated translational research fellowship to train clinician-scientists and a series of funded seed grants awarded to foster research in this area. Our center is a pilot program sponsored by the hospital designed to innovate paradigms of medical care partnered with research. My colleagues and I in the Center have created 3-D models of patients' brains and blood vessels to rehearse neurointerventional procedures in advance, an innovation that has been shown to save resources and—importantly—improve patient outcomes. Our goal is for our center to serve as a national leader to transform the way that care is delivered to children.


My research efforts are focused on finding cures for children with brain tumors and cerebrovascular disease. I am committed to building bridges between clinical practice and scientific research in order to leverage the unique perspective of a surgeon-scientist. The disorders that I treat—brain tumors and cerebrovascular disease—are  linked by similar operative approaches that I use in the hospital and by common biological processes that I study in the lab.

My research is primarily centered on understanding the molecular mechanisms of tumorigenesis and angiogenesis in the central nervous system, in conjunction with efforts of the Vascular Biology Program, led by Dr. Marsha Moses. My work has included basic science and translational studies investigating adult and pediatric brain tumors, moyamoya disease and cerebral arteriovenous malformations. In particular, my laboratory—with colleagues—has discovered novel biomarkers for neurosurgical disease and has studied a class of molecules that markedly influence the malginant nature of tumors and the capacity of blood vessels to grow in the brain. This research has direct impact on brain tumors, moyamoya and arteriovenous malformations.

In particular, I am interested in the development of tests to better screen for the presence, recurrence and progression of brain tumors and cerebrovascular disease using non-invasive biomarkers. My laboratory published the first report describing the successful use of urinary biomarkers to identify brain tumors and has since expanded this work to include—for the first time—the ability of urinary biomarkers to predict therapeutic efficacy in cerebrovascular disease.

This research, supported by the NIH and national foundations, serves as the core of an ongoing five-year national multicenter trial to study brain tumor recurrence and directly complements our mechanistic studies of brain tumor invasion conducted in the Vascular Biology Program. Together, this work has led to the current development of novel therapeutic agents now being studied in our lab.

Our comprehensive patient database, representing the largest experience with pediatric cerebrovascular disease in the world, provides rich source material for ongoing studies. The database allows us to track long-term patient outcomes, compare the results of different surgical and neurointerventional procedures, evaluate newly adopted interventions and improve our quality of care.

My clinical expertise has led to authoring a number of important guidelines and articles about these conditions, including the American Heart Association Guidelines for the Management of Cerebrovascular Disorders in Infants and Children, a New England Journal of Medicine paper on moyamoya disease, and some of the largest studies published on arteriovenous malformations, cavernous malformations and pediatric aneurysms.

The special environment of Boston Children’s Hospital—combining world-class clinical care with internationally renowned scientists—has enabled remarkable advances in the science and treatment of pediatric disease.  Our lab has been fortunate to contribute to these efforts and we continue to work as hard as we can to pave the way for new treatments.

Some of the foundation from our lab for exciting future work includes: 

Smith ER, Manfredi M, Scott RM, Black PM, Moses MA. A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery 2007 Jun; 60(6):E1148-9; discussion E1149.

Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 2008 Apr 15; 14(8):2378-86.

Roach ES (Chair), Golomb M, Adams R, Biller, Daniels JS, deVeber G, Ferriero D, Ichord R, Jones B, Kirkham F, Scott RM, Smith ER. Guidelines for the management of cerebrovascular disorders in infants and children: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2008 Jul 17; 39(9): 2644-91.

Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009 Mar 19; 360(12):1226-37.

Smith ER, McClain CD, Heeney M, Scott RM. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurgery Focus 2009 Apr;26(4):E10.

Gross BA, Scott RM, Smith ER, Management of Brain Arteriovenous Malformations, Lancet, 2014, May 383(9929):1635

Akino T, Han X, Nakayama H, McNeish B, Zurakowski D, Mammoto A, Klagsbrun M, Smith ER, Netrin-1 promotes medulloblastoma cell invasiveness and angiogenesis, and demonstrates elevated expression in tumor tissue and urine of pediatric medulloblastoma patients, Cancer Research 2014 Jul 15;74(14):3716-26

Orbach D, Storey A, Morash D, Estroff J, Smith E, Trenor C, Olson H, Pathogenesis of dural sinus malformations as demonstrated by fetal imaging: a decision-making crucible for parents and clinicians. Journal of Neurointerventional Surgery, 2014 Jul;6 Suppl 1:A69-70.

Weinstock P, Prabhu S, Flynn K, Orbach DB, Smith ER, Optimizing Cerebrovascular Surgical and Endovascular Procedures in Children via Personalized 3-Dimensional Printing, Journal of Neurosurgery, Pediatrics (in press)


Publications powered by Harvard Catalyst Profiles
  1. Titsworth WL, Scott RM, Smith ER. National Analysis of 2454 Pediatric Moyamoya Admissions and the Effect of Hospital Volume on Outcomes. Stroke. 2016 May; 47(5):1303-11.
  2. Smith ER. Structural causes of ischemic and hemorrhagic stroke in children: moyamoya and arteriovenous malformations. Curr Opin Pediatr. 2015 Dec; 27(6):706-11.
  3. Smith ER. Moyamoya Biomarkers. J Korean Neurosurg Soc. 2015 Jun; 57(6):415-21.
  4. Lin N, Smith ER, Scott RM, Orbach DB. Safety of neuroangiography and embolization in children: complication analysis of 697 consecutive procedures in 394 patients. J Neurosurg Pediatr. 2015 Oct; 16(4):432-8.
  5. See AP, Ropper AE, Underberg DL, Robertson RL, Scott RM, Smith ER. Down syndrome and moyamoya: clinical presentation and surgical management. J Neurosurg Pediatr. 2015 Jul; 16(1):58-63.
  6. Gross BA, Smith ER, Scott RM, Orbach DB. Intracranial aneurysms in the youngest patients: characteristics and treatment challenges. Pediatr Neurosurg. 2015; 50(1):18-25.
  7. Gross BA, Storey A, Orbach DB, Scott RM, Smith ER. Microsurgical treatment of arteriovenous malformations in pediatric patients: the Boston Children's Hospital experience. J Neurosurg Pediatr. 2015 Jan; 15(1):71-7.
  8. Baird LC, Smith ER, Ichord R, Piccoli DA, Bernard TJ, Spinner NB, Scott RM, Kamath BM. Moyamoya syndrome associated with Alagille syndrome: outcome after surgical revascularization. J Pediatr. 2015 Feb; 166(2):470-3.
  9. Thakrar R, Robson CD, Vargas SO, Meara JG, Rahbar R, Smith ER. Benign triton tumor: multidisciplinary approach to diagnosis and treatment. Pediatr Dev Pathol. 2014 Sep-Oct; 17(5):400-5.
  10. Gross BA, Scott RM, Smith ER. Management of brain arteriovenous malformations. Lancet. 2014 May 10; 383(9929):1635.
  11. Show all
  12. Yanamadala V, Lin N, Walcott BP, Baird LC, Smith ER. Spontaneous regression of an epidermoid cyst of the cavernous sinus. J Clin Neurosci. 2014 Aug; 21(8):1433-5.
  13. Gross BA, Stone SS, Smith ER. Occipital pial synangiosis. Acta Neurochir (Wien). 2014 Jul; 156(7):1297-300.
  14. Jackson EM, Lin N, Manjila S, Scott RM, Smith ER. Pial synangiosis in patients with moyamoya younger than 2 years of age. J Neurosurg Pediatr. 2014 Apr; 13(4):420-5.
  15. Lin N, Aronson JP, Manjila S, Smith ER, Scott RM. Treatment of Moyamoya disease in the adult population with pial synangiosis. J Neurosurg. 2014 Mar; 120(3):612-7.
  16. Gross BA, Smith ER, Goumnerova L, Proctor MR, Madsen JR, Scott RM. Resection of supratentorial lobar cavernous malformations in children: clinical article.. J Neurosurg Pediatr. 2013 Oct; 12(4):367-73.
  17. Ginat DT, Smith ER, Robertson RL, Scott RM, Schaefer PW. Imaging after direct and indirect extracranial-intracranial bypass surgery. AJR Am J Roentgenol. 2013 Jul; 201(1):W124-32.
  18. Gross BA, Smith ER, Scott RM. Cavernous malformations of the basal ganglia in children. J Neurosurg Pediatr. 2013 Aug; 12(2):171-4.
  19. Robison NJ, Prabhu SP, Sun P, Chi SN, Kieran MW, Manley PE, Cohen LE, Goumnerova L, Smith ER, Scott RM, London WB, Ullrich NJ. Predictors of neoplastic disease in children with isolated pituitary stalk thickening. Pediatr Blood Cancer. 2013 Oct; 60(10):1630-5.
  20. Singla A, Lin N, Ho AL, Scott RM, Smith ER. Vascular collateralization along ventriculoperitoneal shunt catheters in moyamoya disease. J Neurosurg Pediatr. 2013 Jun; 11(6):710-2.
  21. Lohani S, Madsen JR, Bergin AM, Smith ER. Moyamoya disease with mesial temporal sclerosis. J Neurosurg Pediatr. 2013 Jun; 11(6):713-6.
  22. Koss M, Scott RM, Irons MB, Smith ER, Ullrich NJ. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr. 2013 Apr; 11(4):417-25.
  23. Ahn ES, Scott RM, Robertson RL, Smith ER. Chorea in the clinical presentation of moyamoya disease: results of surgical revascularization and a proposed clinicopathological correlation. J Neurosurg Pediatr. 2013 Mar; 11(3):313-9.
  24. Smith ER. Moyamoya arteriopathy. Curr Treat Options Neurol. 2012 Dec; 14(6):549-56.
  25. Smith ER, Scott RM. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. J Neurosurg Pediatr. 2012 Apr; 9(4):353-60.
  26. Ellis MJ, Armstrong D, Vachhrajani S, Kulkarni AV, Dirks PB, Drake JM, Smith ER, Scott RM, Orbach DB. Angioarchitectural features associated with hemorrhagic presentation in pediatric cerebral arteriovenous malformations. J Neurointerv Surg. 2013 May; 5(3):191-5.
  27. Khoriaty E, McClain CD, Permaul P, Smith ER, Rachid R. Intraoperative anaphylaxis induced by the gelatin component of thrombin-soaked gelfoam in a pediatric patient. Ann Allergy Asthma Immunol. 2012 Mar; 108(3):209-10.
  28. Walcott BP, Smith ER, Scott RM, Orbach DB. Dural arteriovenous fistulae in pediatric patients: associated conditions and treatment outcomes. J Neurointerv Surg. 2013 Jan 1; 5(1):6-9.
  29. Walcott BP, Smith ER, Scott RM, Orbach DB. Pial arteriovenous fistulae in pediatric patients: associated syndromes and treatment outcome. J Neurointerv Surg. 2013 Jan 1; 5(1):10-4.
  30. Maher CO, Klimo P, Smith ER. Incidentally discovered lesions. Neurosurg Focus. 2011 Dec; 31(6):1 p preceding E1.
  31. Lin N, Baird L, Koss M, Kopecky KE, Gone E, Ullrich NJ, Scott RM, Smith ER. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression. Neurosurg Focus. 2011 Dec; 31(6):E6.
  32. Kim AH, Kasliwal MK, McNeish B, Silvera VM, Proctor MR, Smith ER. Features of the lumbar spine on magnetic resonance images following sectioning of filum terminale. J Neurosurg Pediatr. 2011 Oct; 8(4):384-9.
  33. Moftakhar P, Smith ER, Choulakian A, Scott RM, Danielpour M. Moyamoya disease in children with congenital dwarfing conditions. Pediatr Neurosurg. 2010; 46(5):373-80.
  34. Kasliwal MK, Rogers GF, Ramkissoon S, Moses-Gardner A, Kurek KC, Smith ER. A rare case of psammomatoid ossifying fibroma in the sphenoid bone reconstructed using autologous particulate exchange cranioplasty. J Neurosurg Pediatr. 2011 Mar; 7(3):238-43.
  35. Nahed BV, Ferreira M, Babu MA, Terry AR, Walcott BP, Kahle KT, Smith ER. Dural scalp and intracranial hemangiomas causing hydrocephalus and venous sinus thrombosis in an infant. J Child Neurol. 2011 Jun; 26(6):777-81.
  36. Magge SN, Smyth MD, Governale LS, Goumnerova L, Madsen J, Munro B, Nalbach SV, Proctor MR, Scott RM, Smith ER. Idiopathic syrinx in the pediatric population: a combined center experience. J Neurosurg Pediatr. 2011 Jan; 7(1):30-6.
  37. Smith ER, Scott RM. Cavernous malformations. Neurosurg Clin N Am. 2010 Jul; 21(3):483-90.
  38. Klimo P, Maher CO, Smith ER. Preface: introduction to pediatric vascular neurosurgery. Neurosurg Clin N Am. 2010 Jul; 21(3):xiii-xiv.
  39. Smith ER, Scott RM. Moyamoya: epidemiology, presentation, and diagnosis. Neurosurg Clin N Am. 2010 Jul; 21(3):543-51.
  40. Scott RM, Smith ER. Introduction: moyamoya disease. Neurosurg Focus. 2009 Apr; 26(4):E1.
  41. Codd PJ, Scott RM, Smith ER. Seckel syndrome and moyamoya. J Neurosurg Pediatr. 2009 Apr; 3(4):320-4.
  42. Smith ER, McClain CD, Heeney M, Scott RM. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Neurosurg Focus. 2009 Apr; 26(4):E10.
  43. Nahed BV, Ferreira M, Naunheim MR, Kahle KT, Proctor MR, Smith ER. Intracranial vasospasm with subsequent stroke after traumatic subarachnoid hemorrhage in a 22-month-old child. J Neurosurg Pediatr. 2009 Apr; 3(4):311-5.
  44. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009 Mar 19; 360(12):1226-37.
  45. Qaiser R, Scott RM, Smith ER. Identification of an association between Robinow syndrome and moyamoya. Pediatr Neurosurg. 2009; 45(1):69-72.
  46. Agarwalla PK, Dunn IF, Turner CD, Ligon KL, Schneider KA, Smith ER. A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature. Pediatr Neurosurg. 2008; 44(6):501-8.
  47. Grondin RT, Scott RM, Smith ER. Pediatric brain tumors. Adv Pediatr. 2009; 56:249-69.
  48. Jha RM, Klimo P, Smith ER. Foramen magnum stenosis from overgrowth of the opisthion in a child with achondroplasia. J Neurosurg Pediatr. 2008 Aug; 2(2):136-8.
  49. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, Ferriero D, Jones BV, Kirkham FJ, Scott RM, Smith ER. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008 Sep; 39(9):2644-91.
  50. Smith ER, Zurakowski D, Saad A, Scott RM, Moses MA. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res. 2008 Apr 15; 14(8):2378-86.
  51. Smith ER, Scott RM. Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus. 2008; 24(2):E17.
  52. Nahed BV, Darbar A, Doiron R, Saad A, Robson CD, Smith ER. Acute hydrocephalus secondary to obstruction of the foramen of monro and cerebral aqueduct caused by a choroid plexus cyst in the lateral ventricle. Case report. J Neurosurg. 2007 Sep; 107(3 Suppl):236-9.
  53. Agarwalla PK, Dunn IF, Scott RM, Smith ER. Tethered cord syndrome. Neurosurg Clin N Am. 2007 Jul; 18(3):531-47.
  54. Smith ER, Manfredi M, Scott RM, Black PM, Moses MA. A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery. 2007 Jun; 60(6):E1148-9; discussion E1149.
  55. Dunn IF, Agarwalla PK, Papanastassiou AM, Butler WE, Smith ER. Multiple pilocytic astrocytomas of the cerebellum in a 17-year-old patient with neurofibromatosis type I. Childs Nerv Syst. 2007 Oct; 23(10):1191-4.
  56. Klimo P, Khalil A, Slotkin JR, Smith ER, Scott RM, Goumnerova LC. Wound complications associated with the use of bovine serum albumin-glutaraldehyde surgical adhesive in pediatric patients. Neurosurgery. 2007 Apr; 60(4 Suppl 2):305-9; discussion 309.
  57. Smith ER, Butler WE, Barker FG. Is there a "July phenomenon" in pediatric neurosurgery at teaching hospitals? J Neurosurg. 2006 Sep; 105(3 Suppl):169-76.
  58. Kim AH, Maher CO, Smith ER. Lumbar intramedullary spinal schistosomiasis presenting as progressive paraparesis: case report. Neurosurgery. 2006 May; 58(5):E996; discussion E996.
  59. Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics. 2005 Nov; 116(5):e694-701.
  60. Smith ER, Scott RM. Surgical management of moyamoya syndrome. Skull Base. 2005 Feb; 15(1):15-26.
  61. Smith ER, Madsen JR. Neurosurgical aspects of critical care neurology. Semin Pediatr Neurol. 2004 Jun; 11(2):169-78.
  62. Smith ER, Madsen JR. Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure. Semin Pediatr Neurol. 2004 Jun; 11(2):89-104.
  63. Smith ER, Butler WE, Barker FG. Craniotomy for resection of pediatric brain tumors in the United States, 1988 to 2000: effects of provider caseloads and progressive centralization and specialization of care. Neurosurgery. 2004 Mar; 54(3):553-63; discussion 563-5.
  64. Smith ER, Butler WE, Barker FG. In-hospital mortality rates after ventriculoperitoneal shunt procedures in the United States, 1998 to 2000: relation to hospital and surgeon volume of care. J Neurosurg. 2004 Feb; 100(2 Suppl Pediatrics):90-7.
  65. Smith ER, Chapman PH, Ogilvy CS. Far posterior subtemporal approach to the dorsolateral brainstem and tentorial ring: technique and clinical experience. Neurosurgery. 2003 Feb; 52(2):364-8; discussion 368-9.
  66. Smith ER, Carter BS, Ogilvy CS. Proposed use of prophylactic decompressive craniectomy in poor-grade aneurysmal subarachnoid hemorrhage patients presenting with associated large sylvian hematomas. Neurosurgery. 2002 Jul; 51(1):117-24; discussion 124.
  67. Smith ER, Butler WE, Ogilvy CS. Surgical approaches to vascular anomalies of the child's brain. Curr Opin Neurol. 2002 Apr; 15(2):165-71.
  68. Smith ER, Ott M, Wain J, Louis DN, Chiocca EA. Massive growth of a meningioma into the brachial plexus and thoracic cavity after intraspinal and supraclavicular resection. Case report and review of the literature. J Neurosurg. 2002 Jan; 96(1 Suppl):107-11.
To schedule an appointment: Call 617-355-6008 or Request an Appointment


We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944